448 related articles for article (PubMed ID: 35078444)
41. Effect of Sequential or Active Choice for Colorectal Cancer Screening Outreach: A Randomized Clinical Trial.
Mehta SJ; Induru V; Santos D; Reitz C; McAuliffe T; Orellana C; Volpp KG; Asch DA; Doubeni CA
JAMA Netw Open; 2019 Aug; 2(8):e1910305. PubMed ID: 31469393
[TBL] [Abstract][Full Text] [Related]
42. Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial.
O'Connor EA; Vollmer WM; Petrik AF; Green BB; Coronado GD
Trials; 2020 Jan; 21(1):91. PubMed ID: 31941527
[TBL] [Abstract][Full Text] [Related]
43. Improving Colorectal Cancer Screening in a Regional Safety-Net Health System over a 10-Year Period: Lessons for Population Health.
Halm EA; Nair RG; Hu E; Wang L; Lykken JM; Ortiz C; Kim EJ; Santini NO; Moran B; Skinner CS
J Gen Intern Med; 2024 May; 39(6):978-984. PubMed ID: 37932541
[TBL] [Abstract][Full Text] [Related]
44. Two-year follow-up of the effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers.
Baker DW; Brown T; Goldman SN; Liss DT; Kollar S; Balsley K; Lee JY; Buchanan DR
Cancer Causes Control; 2015 Nov; 26(11):1685-90. PubMed ID: 26337733
[TBL] [Abstract][Full Text] [Related]
45. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
46. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
[TBL] [Abstract][Full Text] [Related]
47. The effectiveness of the FLU-FOBT program in primary care a randomized trial.
Potter MB; Walsh JM; Yu TM; Gildengorin G; Green LW; McPhee SJ
Am J Prev Med; 2011 Jul; 41(1):9-16. PubMed ID: 21665058
[TBL] [Abstract][Full Text] [Related]
48. Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population.
Karlitz JJ; Fendrick AM; Bhatt J; Coronado GD; Jeyakumar S; Smith NJ; Plescia M; Brooks D; Limburg P; Lieberman D
Popul Health Manag; 2022 Jun; 25(3):343-351. PubMed ID: 34958279
[TBL] [Abstract][Full Text] [Related]
49. Effect of Physician Notification Regarding Nonadherence to Colorectal Cancer Screening on Patient Participation in Fecal Immunochemical Test Cancer Screening: A Randomized Clinical Trial.
Rat C; Pogu C; Le Donné D; Latour C; Bianco G; Nanin F; Cowppli-Bony A; Gaultier A; Nguyen JM
JAMA; 2017 Sep; 318(9):816-824. PubMed ID: 28873160
[TBL] [Abstract][Full Text] [Related]
50. Uptake of colorectal cancer screening after mailed fecal immunochemical test (FIT) outreach in a newly eligible 45-49-year-old community health center population.
O'Leary MC; Reuland DS; Correa SY; Moore AA; Malo TL; Tan X; Rohweder CL; Wheeler SB; Brenner AT
Cancer Causes Control; 2023 Dec; 34(Suppl 1):125-133. PubMed ID: 37300632
[TBL] [Abstract][Full Text] [Related]
51. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
Todorov K; Wilson C; Sharplin G; Corsini N
Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
[TBL] [Abstract][Full Text] [Related]
52. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
[TBL] [Abstract][Full Text] [Related]
53. Selection of patients for large mailed fecal immunochemical test colorectal cancer screening outreach programs: A systematic review.
Wang A; Lee B; Patel S; Whitaker E; Issaka RB; Somsouk M
J Med Screen; 2021 Dec; 28(4):379-388. PubMed ID: 33683155
[TBL] [Abstract][Full Text] [Related]
54. Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time.
Doubeni CA; Laiyemo AO; Young AC; Klabunde CN; Reed G; Field TS; Fletcher RH
Ann Fam Med; 2010; 8(4):299-307. PubMed ID: 20644184
[TBL] [Abstract][Full Text] [Related]
55. Applying the Plan-Do-Study-Act (PDSA) approach to a large pragmatic study involving safety net clinics.
Coury J; Schneider JL; Rivelli JS; Petrik AF; Seibel E; D'Agostini B; Taplin SH; Green BB; Coronado GD
BMC Health Serv Res; 2017 Jun; 17(1):411. PubMed ID: 28629348
[TBL] [Abstract][Full Text] [Related]
56. Mail-Based Self-Sampling to Complete Colorectal Cancer Screening: Accelerating Colorectal Cancer Screening and Follow-up Through Implementation Science.
Gupta S; Barnes A; Brenner AT; Campbell J; Davis M; English K; Hoover S; Kim K; Kobrin S; Lance P; Mishra SI; Oliveri JM; Reuland DS; Subramanian S; Coronado GD
Prev Chronic Dis; 2023 Dec; 20():E112. PubMed ID: 38060411
[TBL] [Abstract][Full Text] [Related]
57. Primary care colorectal cancer screening recommendation patterns: associated factors and screening outcomes.
Feldstein AC; Perrin N; Liles EG; Smith DH; Rosales AG; Schneider JL; Lafata JE; Myers RE; Mosen DM; Glasgow RE
Med Decis Making; 2012; 32(1):198-208. PubMed ID: 21652776
[TBL] [Abstract][Full Text] [Related]
58. Primary care provider perspectives on the role of community pharmacy in colorectal cancer screening: a qualitative study.
Brenner AT; Rohweder CL; Wangen M; Atkins DL; Ceballos RM; Correa S; Ferrari RM; Issaka RB; Ittes A; Odebunmi OO; Reuland DS; Waters AR; Wheeler SB; Shah PD
BMC Health Serv Res; 2023 Aug; 23(1):892. PubMed ID: 37612656
[TBL] [Abstract][Full Text] [Related]
59. Health plan adaptations to a mailed outreach program for colorectal cancer screening among Medicaid and Medicare enrollees: the BeneFIT study.
Coronado GD; Schneider JL; Green BB; Coury JK; Schwartz MR; Kulkarni-Sharma Y; Baldwin LM
Implement Sci; 2020 Sep; 15(1):77. PubMed ID: 32933525
[TBL] [Abstract][Full Text] [Related]
60. Design of a randomized controlled trial to assess the comparative effectiveness of a multifaceted intervention to improve adherence to colorectal cancer screening among patients cared for in a community health center.
Baker DW; Brown T; Buchanan DR; Weil J; Cameron KA; Ranalli L; Ferreira MR; Stephens Q; Balsley K; Goldman SN; Wolf MS
BMC Health Serv Res; 2013 Apr; 13():153. PubMed ID: 23627550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
